| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.03 | 0.6 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.6 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |